BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 16933323)

  • 1. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
    Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies.
    Sauer PW; Burky JE; Wesson MC; Sternard HD; Qu L
    Biotechnol Bioeng; 2000 Mar; 67(5):585-97. PubMed ID: 10649233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single nutrient feed supports both chemically defined NS0 and CHO fed-batch processes: Improved productivity and lactate metabolism.
    Ma N; Ellet J; Okediadi C; Hermes P; McCormick E; Casnocha S
    Biotechnol Prog; 2009; 25(5):1353-63. PubMed ID: 19637321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NS0 cell damage by high gas velocity sparging in protein-free and cholesterol-free cultures.
    Zhu Y; Cuenca JV; Zhou W; Varma A
    Biotechnol Bioeng; 2008 Nov; 101(4):751-60. PubMed ID: 18814288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.
    Stansfield SH; Allen EE; Dinnis DM; Racher AJ; Birch JR; James DC
    Biotechnol Bioeng; 2007 Jun; 97(2):410-24. PubMed ID: 17115445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved fermentation processes for NS0 cell lines expressing human antibodies and glutamine synthetase.
    Dempsey J; Ruddock S; Osborne M; Ridley A; Sturt S; Field R
    Biotechnol Prog; 2003; 19(1):175-8. PubMed ID: 12573022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis.
    Frahm B; Lane P; Märkl H; Pörtner R
    Bioprocess Biosyst Eng; 2003 Nov; 26(1):1-10. PubMed ID: 14505167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defined protein and animal component-free NS0 fed-batch culture.
    Spens E; Häggström L
    Biotechnol Bioeng; 2007 Dec; 98(6):1183-94. PubMed ID: 17516495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production.
    Lee YY; Yap MG; Hu WS; Wong KT
    Biotechnol Prog; 2003; 19(2):501-9. PubMed ID: 12675594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level production of a monoclonal antibody in murine myeloma cells by perfusion culture using a gravity settler.
    Choo CY; Tian Y; Kim WS; Blatter E; Conary J; Brady CP
    Biotechnol Prog; 2007; 23(1):225-31. PubMed ID: 17269692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
    Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
    Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic characteristics of GS-nS0 myeloma cells producing anti-CD25 monoclonal antibody in serum-free culture].
    Zhao L; Fan L; Zhang X; Tan W
    Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1069-76. PubMed ID: 19835150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of an artificially selected GS-NS0 variant with increased resistance to apoptosis.
    Browne SM; Al-Rubeai M
    Biotechnol Bioeng; 2011 Apr; 108(4):880-92. PubMed ID: 21404261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment.
    Huang YM; Hu W; Rustandi E; Chang K; Yusuf-Makagiansar H; Ryll T
    Biotechnol Prog; 2010; 26(5):1400-10. PubMed ID: 20945494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a fed-batch culture process for enhanced production of recombinant human antithrombin by Chinese hamster ovary cells.
    Kuwae S; Ohda T; Tamashima H; Miki H; Kobayashi K
    J Biosci Bioeng; 2005 Nov; 100(5):502-10. PubMed ID: 16384788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
    Spens E; Häggström L
    Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced productivity of NS0 cells in fed-batch culture with cholesterol nanoparticle supplementation.
    Wu Y; Ma N; Wyslouzil BE; Chalmers JJ; McCormick E; Casnocha SA
    Biotechnol Prog; 2011; 27(3):796-802. PubMed ID: 21509955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a cholesterol-independent, non-GS NS0 cell line through chemical treatment and application for high titer antibody production.
    Li J; Gu W; Edmondson DG; Lu C; Vijayasankaran N; Figueroa B; Stevenson D; Ryll T; Li F
    Biotechnol Bioeng; 2012 Jul; 109(7):1685-92. PubMed ID: 22252532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.